Daniel Delev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Delev has a total of 191 co-authors. Here are the top co-authors by number of shared publications:
Alexander Grote
Departments of1Neurosurgery and
4 shared publications- Ingmar Blümcke
Institute of Neuropathology University Hospitals Erlangen Erlangen Germany
4 shared publications - Roland Coras
Department of Neuropathology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Germany
4 shared publications - Aniella Bak
Department of Epileptology, Neurology, RWTH University Hospital Aachen, Germany
3 shared publications Dieter Henrik Heiland
Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nürnberg , Erlangen
3 shared publications- Hajo Hamer
Epilepsy Center, Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
3 shared publications
Latest Publications
- Open Access
Repetitive clustered low‐voltage fast activity on intracranial electroencephalogram in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy: A candidate electroencephalographic biomarker study
Objective: Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug‐resistant focal epilepsy. It is often magnetic resonance imaging‐negative or radiologically resembles focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial electroencephalographic (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. Methods: We analyzed long‐term stereo‐EEG and subdural recordings in a retrospective multicenter test cohort (18 MOGHE, 20 non‐MOGHE) to identify an iEEG pattern distinguishing MOGHE from other developmental brain lesions. We then evaluated its diagnostic performance by blinded visual assessment in an independent single‐center validation cohort (11 MOGHE, 11 non‐MOGHE). Firth‐penalized multivariable logistic regression tested whether MOGHE histology independently predicted the presence of this pattern after adjustment for spasms, frontal localization, age at seizure onset, and age at implantation. Finally, within MOGHE, we assessed whether resection of the territory exhibiting this pattern was associated with postsurgical seizure freedom. Results: We identified highly stereotyped clusters of very brief low‐voltage fast activity (LVFA), recurring in statuslike episodes lasting several minutes and sometimes lacking clear clinical symptoms. LVFA clusters occurred in 16 of 18 MOGHE and in no non‐MOGHE patients in the test cohort. In the validation cohort, visual identification of LVFA clusters correctly classified 10 of 11 MOGHE and 10 of 11 non‐MOGHE cases (overall agreement = 90.9%, 95% Wilson confidence interval = 72.2%–97.5%). MOGHE histology was the dominant independent predictor of LVFA clusters. Within MOGHE, resection of LVFA cluster territory was associated with postsurgical seizure freedom (Mann–Whitney U ‐test, p = .0021). Significance: Because LVFA clusters can be recognized visually on routine iEEG without specialized software, they may provide a clinically applicable candidate biomarker for presurgical identification of MOGHE and support surgical planning and outcome prediction. Prospective studies should validate their diagnostic and prognostic utility.
Open AccessRepetitive clustered low‐voltage fast activity on intracranial electroencephalogram in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy: A candidate electroencephalographic biomarker study
Objective: Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug‐resistant focal epilepsy. It is often magnetic resonance imaging‐negative or radiologically resembles focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial electroencephalographic (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. Methods: We analyzed long‐term stereo‐EEG and subdural recordings in a retrospective multicenter test cohort (18 MOGHE, 20 non‐MOGHE) to identify an iEEG pattern distinguishing MOGHE from other developmental brain lesions. We then evaluated its diagnostic performance by blinded visual assessment in an independent single‐center validation cohort (11 MOGHE, 11 non‐MOGHE). Firth‐penalized multivariable logistic regression tested whether MOGHE histology independently predicted the presence of this pattern after adjustment for spasms, frontal localization, age at seizure onset, and age at implantation. Finally, within MOGHE, we assessed whether resection of the territory exhibiting this pattern was associated with postsurgical seizure freedom. Results: We identified highly stereotyped clusters of very brief low‐voltage fast activity (LVFA), recurring in statuslike episodes lasting several minutes and sometimes lacking clear clinical symptoms. LVFA clusters occurred in 16 of 18 MOGHE and in no non‐MOGHE patients in the test cohort. In the validation cohort, visual identification of LVFA clusters correctly classified 10 of 11 MOGHE and 10 of 11 non‐MOGHE cases (overall agreement = 90.9%, 95% Wilson confidence interval = 72.2%–97.5%). MOGHE histology was the dominant independent predictor of LVFA clusters. Within MOGHE, resection of LVFA cluster territory was associated with postsurgical seizure freedom (Mann–Whitney U ‐test, p = .0021). Significance: Because LVFA clusters can be recognized visually on routine iEEG without specialized software, they may provide a clinically applicable candidate biomarker for presurgical identification of MOGHE and support surgical planning and outcome prediction. Prospective studies should validate their diagnostic and prognostic utility.
- Open Access
Deep whole genome sequencing of epileptogenic brain lesions
Objective: Malformations of cortical development and low‐grade epilepsy‐associated tumors often cause drug‐resistant lesional focal epilepsy (LFE) amenable to surgical treatment. Genetic testing of resected brain tissue can provide diagnostic and mechanistic information and may eventually support personalized treatment approaches. However, systematic >300× whole genome sequencing (GS) of bulk epileptogenic lesions, particularly after nondiagnostic deep exome sequencing and array‐based genotyping, has not been evaluated. Methods: Here, we performed deep GS (>300× coverage) on 33 epileptogenic brain lesions from individuals with LFE, selected for lesions with a high prior probability of a genetic finding, all of whom had negative results for candidate germline or somatic variants in previous deep exome sequencing (ES; >350× coverage) and array‐based genotyping. Results: We identified candidate somatic variants in known LFE‐associated genes in seven of 33 participants (21%). Two participants had two candidate variants each. In total, three of 33 participants (9%) had variants that could only be detected by GS: two deletions in TSC2 , two deletions in NPRL3 , and an exonic inversion in FGFR1 . Three individuals had germline polymorphisms that may represent modulators or risk factors. Exploratory mutational signature analysis revealed clocklike signatures and a correlation between mutational signatures, age at seizure onset, and histopathology, indicating an age‐related mechanism of mutation. Significance: Deep GS establishes the feasibility of genome‐wide profiling at a depth relevant to low‐variant allelic frequency mosaicism and reveals candidate variants missed by ES, particularly complex structural variants. As sequencing costs decrease, GS may complement other technologies in somatic variant detection, enabling more widespread clinical implementation of tissue sequencing in epilepsy surgery. Further studies are needed to address the remaining conceptual and technological challenges in somatic variant detection.
Open AccessDeep whole genome sequencing of epileptogenic brain lesions
Objective: Malformations of cortical development and low‐grade epilepsy‐associated tumors often cause drug‐resistant lesional focal epilepsy (LFE) amenable to surgical treatment. Genetic testing of resected brain tissue can provide diagnostic and mechanistic information and may eventually support personalized treatment approaches. However, systematic >300× whole genome sequencing (GS) of bulk epileptogenic lesions, particularly after nondiagnostic deep exome sequencing and array‐based genotyping, has not been evaluated. Methods: Here, we performed deep GS (>300× coverage) on 33 epileptogenic brain lesions from individuals with LFE, selected for lesions with a high prior probability of a genetic finding, all of whom had negative results for candidate germline or somatic variants in previous deep exome sequencing (ES; >350× coverage) and array‐based genotyping. Results: We identified candidate somatic variants in known LFE‐associated genes in seven of 33 participants (21%). Two participants had two candidate variants each. In total, three of 33 participants (9%) had variants that could only be detected by GS: two deletions in TSC2 , two deletions in NPRL3 , and an exonic inversion in FGFR1 . Three individuals had germline polymorphisms that may represent modulators or risk factors. Exploratory mutational signature analysis revealed clocklike signatures and a correlation between mutational signatures, age at seizure onset, and histopathology, indicating an age‐related mechanism of mutation. Significance: Deep GS establishes the feasibility of genome‐wide profiling at a depth relevant to low‐variant allelic frequency mosaicism and reveals candidate variants missed by ES, particularly complex structural variants. As sequencing costs decrease, GS may complement other technologies in somatic variant detection, enabling more widespread clinical implementation of tissue sequencing in epilepsy surgery. Further studies are needed to address the remaining conceptual and technological challenges in somatic variant detection.
- Open Access
- 1 August 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (5) , 1651-1667
Astrocyte subtype‐specific alterations in the dentate gyrus of individuals with mesial temporal lobe epilepsy
Objective: Epilepsy affects approximately 50 million people worldwide and, although primarily attributed to neuronal dysfunction, increasing evidence highlights a critical role of glial cells, particularly astrocytes, in the pathophysiological mechanisms. Mesial temporal lobe epilepsy (MTLE), the most common form of drug‐resistant epilepsy, is frequently associated with hippocampal sclerosis (HS) and pronounced astrogliosis. Given the limited efficacy of current anti‐seizure medication (ASM) and the side effects of surgical hippocampus removal, there is a need for more specific and effective therapies that potentially address non‐neuronal mechanisms. Astrocytes, with their inherent heterogeneity, are key candidates for such approaches due to their role in regulating and maintaining neuronal activity. Methods: To investigate subtype‐specific astrocyte alterations in MTLE, we performed immunofluorescence analyses of human dentate gyrus (DG) tissue from MTLE patients (HS1, HS2, and noHS according to the International League Against Epilepsy (ILAE) consensus classification of HS in temporal lobe epilepsy) and postmortem controls. We analyzed the expression and spatial distribution of selected functionally relevant astrocytic proteins, including glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), excitatory amino acid transporter 2 (EAAT2), and aquaporin‐4 (AQP4). Results: In control tissue, astrocyte subtypes, characterized by combinatorial expression of GFAP, GS, EAAT2, and AQP4, displayed distinct, layer‐specific protein expression profiles across the DG compartments. While the subtype identities were largely preserved in MTLE, localization and expression levels of GFAP, EAAT2, and AQP4 were dramatically altered, suggesting functional deficits in glutamate transport and water homeostasis. Since GS expression was unaffected by MTLE, it served as a proxy to quantify the number of astrocytes. In contrast to existing reports, we found that astrocyte numbers did not differ between control and MTLE patients. Significance: Our findings demonstrate that astrocyte reactivity in MTLE is not uniform but occurs in a subtype‐ and region‐specific manner. This highlights astrocyte heterogeneity as an important feature of MTLE pathology and underscores the need to consider astrocyte diversity in understanding disease mechanisms and developing precision medicine‐based therapeutic strategies. Plain Language Summary: Epilepsy is usually studied as a disease of nerve cells, but support cells, called astrocytes, are also involved. We studied brain tissue from patients with a common form of drug‐resistant epilepsy and found that different groups of astrocytes showed distinct changes in proteins that help control brain activity and water movement in the brain. Although the overall number of astrocytes did not change compared with postmortem control patients, the cells displayed strong signs of disease‐related reactivity. Our findings highlight astrocytes as potential targets for future epilepsy treatments.
- 1 August 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (5) , 1651-1667
Open AccessAstrocyte subtype‐specific alterations in the dentate gyrus of individuals with mesial temporal lobe epilepsy
Objective: Epilepsy affects approximately 50 million people worldwide and, although primarily attributed to neuronal dysfunction, increasing evidence highlights a critical role of glial cells, particularly astrocytes, in the pathophysiological mechanisms. Mesial temporal lobe epilepsy (MTLE), the most common form of drug‐resistant epilepsy, is frequently associated with hippocampal sclerosis (HS) and pronounced astrogliosis. Given the limited efficacy of current anti‐seizure medication (ASM) and the side effects of surgical hippocampus removal, there is a need for more specific and effective therapies that potentially address non‐neuronal mechanisms. Astrocytes, with their inherent heterogeneity, are key candidates for such approaches due to their role in regulating and maintaining neuronal activity. Methods: To investigate subtype‐specific astrocyte alterations in MTLE, we performed immunofluorescence analyses of human dentate gyrus (DG) tissue from MTLE patients (HS1, HS2, and noHS according to the International League Against Epilepsy (ILAE) consensus classification of HS in temporal lobe epilepsy) and postmortem controls. We analyzed the expression and spatial distribution of selected functionally relevant astrocytic proteins, including glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), excitatory amino acid transporter 2 (EAAT2), and aquaporin‐4 (AQP4). Results: In control tissue, astrocyte subtypes, characterized by combinatorial expression of GFAP, GS, EAAT2, and AQP4, displayed distinct, layer‐specific protein expression profiles across the DG compartments. While the subtype identities were largely preserved in MTLE, localization and expression levels of GFAP, EAAT2, and AQP4 were dramatically altered, suggesting functional deficits in glutamate transport and water homeostasis. Since GS expression was unaffected by MTLE, it served as a proxy to quantify the number of astrocytes. In contrast to existing reports, we found that astrocyte numbers did not differ between control and MTLE patients. Significance: Our findings demonstrate that astrocyte reactivity in MTLE is not uniform but occurs in a subtype‐ and region‐specific manner. This highlights astrocyte heterogeneity as an important feature of MTLE pathology and underscores the need to consider astrocyte diversity in understanding disease mechanisms and developing precision medicine‐based therapeutic strategies. Plain Language Summary: Epilepsy is usually studied as a disease of nerve cells, but support cells, called astrocytes, are also involved. We studied brain tissue from patients with a common form of drug‐resistant epilepsy and found that different groups of astrocytes showed distinct changes in proteins that help control brain activity and water movement in the brain. Although the overall number of astrocytes did not change compared with postmortem control patients, the cells displayed strong signs of disease‐related reactivity. Our findings highlight astrocytes as potential targets for future epilepsy treatments.
- 19 June 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2461-2471
Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival
Background: Glioblastoma (GB) is the most aggressive primary brain tumor in adults. Tumor-associated epilepsy (TAE) at diagnosis is common, yet its prognostic significance remains unclear. Methods: We analyzed a retrospective multicenter test cohort of 855 GB patients (Aachen, Hamburg, Bielefeld) and validated findings in a prospectively collected cohort of 344 patients (Erlangen). Survival was assessed using multivariable Cox regression, propensity score matching, and interaction modeling of TAE and extent of resection (EOR). Molecular profiling included methylation-based classification, epigenetic deconvolution, and spatial transcriptomics. Results: Tumor-associated epilepsy was independently associated with improved survival (hazard ratio [HR] 0.81, 95% CI 0.69-0.99, P = .036, absolute survival advantage ∼4-5 months). This effect was validated in the independent cohort (C-index 0.68, 95% CI 0.62–0.74) and persisted in propensity-matched analyses (HR 0.74, 95% CI 0.56-0.96, P = .027). Interaction modeling revealed that gross total resection (GTR) improved survival in both groups but particularly in patients with TAE (EOR interaction HR 0.69, 95% CI 0.49-0.99, P = .041). In this subgroup, partial resection provided no significant advantage over biopsy, whereas patients without seizures benefited incrementally from both partial resection and GTR. Molecular analysis demonstrated enrichment of the RTK II subtype, differentiated cell states, and an inflammatory microenvironment in GB with TAE; tumors without seizures displayed neuronal and stem-like features. Functional validation using electrogenomics showed that GB cortical slices with increased inflammatory score exhibited synchronization of action potentials characteristic for seizure-like epileptiform activity. Conclusions: Tumor-associated epilepsy at diagnosis is a favorable prognostic marker in GB, defining a biologically distinct subgroup. Seizure status modifies the prognostic effect of surgical resection, underscoring the importance of GTR particularly in patients presenting with TAE.
- 19 June 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2461-2471
Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival
Background: Glioblastoma (GB) is the most aggressive primary brain tumor in adults. Tumor-associated epilepsy (TAE) at diagnosis is common, yet its prognostic significance remains unclear. Methods: We analyzed a retrospective multicenter test cohort of 855 GB patients (Aachen, Hamburg, Bielefeld) and validated findings in a prospectively collected cohort of 344 patients (Erlangen). Survival was assessed using multivariable Cox regression, propensity score matching, and interaction modeling of TAE and extent of resection (EOR). Molecular profiling included methylation-based classification, epigenetic deconvolution, and spatial transcriptomics. Results: Tumor-associated epilepsy was independently associated with improved survival (hazard ratio [HR] 0.81, 95% CI 0.69-0.99, P = .036, absolute survival advantage ∼4-5 months). This effect was validated in the independent cohort (C-index 0.68, 95% CI 0.62–0.74) and persisted in propensity-matched analyses (HR 0.74, 95% CI 0.56-0.96, P = .027). Interaction modeling revealed that gross total resection (GTR) improved survival in both groups but particularly in patients with TAE (EOR interaction HR 0.69, 95% CI 0.49-0.99, P = .041). In this subgroup, partial resection provided no significant advantage over biopsy, whereas patients without seizures benefited incrementally from both partial resection and GTR. Molecular analysis demonstrated enrichment of the RTK II subtype, differentiated cell states, and an inflammatory microenvironment in GB with TAE; tumors without seizures displayed neuronal and stem-like features. Functional validation using electrogenomics showed that GB cortical slices with increased inflammatory score exhibited synchronization of action potentials characteristic for seizure-like epileptiform activity. Conclusions: Tumor-associated epilepsy at diagnosis is a favorable prognostic marker in GB, defining a biologically distinct subgroup. Seizure status modifies the prognostic effect of surgical resection, underscoring the importance of GTR particularly in patients presenting with TAE.
- Open Access
A novel diagnostic intracranial EEG biomarker in MOGHE
Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug-resistant focal epilepsy. It is often MRI-negative or shows imaging features mimicking focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial EEG (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. In a retrospective multicenter test cohort of 38 patients (18 MOGHE, 20 non-MOGHE), we analyzed long-term stereo-EEG and subdural recordings. Only MOGHE patients showed highly stereotyped clusters of very brief low-voltage fast activity (LVFA) events, organized into status-like 3 to 12-minute episodes that often lacked clear clinical symptoms. LVFA clusters were present in 16/18 MOGHE and 0/22 non-MOGHE patients. We then tested diagnostic performance in an independent, blinded single-center validation cohort of 22 patients (11 MOGHE, 11 non-MOGHE), in which visual identification of LVFA clusters correctly classified 10/11 MOGHE and 10/11 non-MOGHE cases (Cohen’s κ=0.82). Penalized logistic regression further confirmed MOGHE histology as the strongest predictor of LVFA clusters, independent of age and lobe localization. Because LVFA clusters can be recognized visually on routine intracranial EEG recordings without specialized software, this biomarker is readily applicable in clinical practice and may improve presurgical identification of MOGHE. Future prospective studies should determine whether its recognition influences surgical planning, improves outcome prediction, or facilitates selection of patients for mechanism-based therapies. Highlights: Clusters of brief LVFA in intracranial EEG are a lesion-specific biomarker of MOGHE compared to mMCD and FCD2 LVFA clusters reliably distinguished MOGHE from non-MOGHE lesions (mMCD and FCD2) in both a multicenter test cohort and an independent blinded validation cohort. Younger age at seizure onset is a secondary independent modifier, while frontal localization and age at intracranial recording are not. Clinicians can detect LVFA clusters on continuous intracranial EEG using routine montages and ≥60-second review windows, without any specialized software. LVFA clusters show a characteristic temporal organization and burden in MOGHE, indicating a distinct pattern of pathological network activity in this lesion type.
Open AccessA novel diagnostic intracranial EEG biomarker in MOGHE
Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE) is a recently recognized cause of drug-resistant focal epilepsy. It is often MRI-negative or shows imaging features mimicking focal cortical dysplasias, which makes recognition difficult and limits presurgical counseling. We aimed to identify an intracranial EEG (iEEG) biomarker that distinguishes MOGHE from other developmental brain lesions encountered in epilepsy surgery. In a retrospective multicenter test cohort of 38 patients (18 MOGHE, 20 non-MOGHE), we analyzed long-term stereo-EEG and subdural recordings. Only MOGHE patients showed highly stereotyped clusters of very brief low-voltage fast activity (LVFA) events, organized into status-like 3 to 12-minute episodes that often lacked clear clinical symptoms. LVFA clusters were present in 16/18 MOGHE and 0/22 non-MOGHE patients. We then tested diagnostic performance in an independent, blinded single-center validation cohort of 22 patients (11 MOGHE, 11 non-MOGHE), in which visual identification of LVFA clusters correctly classified 10/11 MOGHE and 10/11 non-MOGHE cases (Cohen’s κ=0.82). Penalized logistic regression further confirmed MOGHE histology as the strongest predictor of LVFA clusters, independent of age and lobe localization. Because LVFA clusters can be recognized visually on routine intracranial EEG recordings without specialized software, this biomarker is readily applicable in clinical practice and may improve presurgical identification of MOGHE. Future prospective studies should determine whether its recognition influences surgical planning, improves outcome prediction, or facilitates selection of patients for mechanism-based therapies. Highlights: Clusters of brief LVFA in intracranial EEG are a lesion-specific biomarker of MOGHE compared to mMCD and FCD2 LVFA clusters reliably distinguished MOGHE from non-MOGHE lesions (mMCD and FCD2) in both a multicenter test cohort and an independent blinded validation cohort. Younger age at seizure onset is a secondary independent modifier, while frontal localization and age at intracranial recording are not. Clinicians can detect LVFA clusters on continuous intracranial EEG using routine montages and ≥60-second review windows, without any specialized software. LVFA clusters show a characteristic temporal organization and burden in MOGHE, indicating a distinct pattern of pathological network activity in this lesion type.
- Open Access
- 12 January 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Neuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration
Background: Gangliogliomas (GGs) are low-grade glioneuronal tumors that frequently present with drug-resistant epilepsy. Although their indolent course contrasts with their high epileptogenic potential, the oncogenic mechanisms sustaining neuronal precursor-like populations within the tumor microenvironment remain poorly defined. Methods: We performed spatial transcriptomic profiling on eight histologically confirmed GGs and matched healthy cortex to map the cellular and molecular architecture of the tumor microenvironment. Integrated analysis with weighted gene correlation network analysis (WGCNA) defined recurrent oncogenic programs and spatially resolved tumor-stroma interactions. Results: Eight conserved gene modules emerged, encompassing physiological cortical, reactive glial, and oncopathological programs. The latter captured extracellular matrix (ECM) remodeling, vascular-immune signaling, and persistence of immature, proliferative neuronal-like states. Spatial modeling revealed that these oncopathological programs form structured niches at the tumor-brain interface, where radial glia-derived neuronal-like tumor cells coexist with immune and stromal elements engaged in ECM turnover and cytokine signaling. Conclusions: Ganglioglioma represents a hybrid glioneuronal neoplasm in which developmental neuronal programs are co-opted by tumor-associated stromal and immune cues. This convergence establishes a permissive oncogenic niche that sustains precursor-like tumor cells and provides a mechanistic basis for both the tumor’s benign growth and its intrinsic epileptogenicity.
- 12 January 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Open AccessNeuronal precursor cell persistence in ganglioglioma is associated with extracellular matrix remodeling and immune cell infiltration
Background: Gangliogliomas (GGs) are low-grade glioneuronal tumors that frequently present with drug-resistant epilepsy. Although their indolent course contrasts with their high epileptogenic potential, the oncogenic mechanisms sustaining neuronal precursor-like populations within the tumor microenvironment remain poorly defined. Methods: We performed spatial transcriptomic profiling on eight histologically confirmed GGs and matched healthy cortex to map the cellular and molecular architecture of the tumor microenvironment. Integrated analysis with weighted gene correlation network analysis (WGCNA) defined recurrent oncogenic programs and spatially resolved tumor-stroma interactions. Results: Eight conserved gene modules emerged, encompassing physiological cortical, reactive glial, and oncopathological programs. The latter captured extracellular matrix (ECM) remodeling, vascular-immune signaling, and persistence of immature, proliferative neuronal-like states. Spatial modeling revealed that these oncopathological programs form structured niches at the tumor-brain interface, where radial glia-derived neuronal-like tumor cells coexist with immune and stromal elements engaged in ECM turnover and cytokine signaling. Conclusions: Ganglioglioma represents a hybrid glioneuronal neoplasm in which developmental neuronal programs are co-opted by tumor-associated stromal and immune cues. This convergence establishes a permissive oncogenic niche that sustains precursor-like tumor cells and provides a mechanistic basis for both the tumor’s benign growth and its intrinsic epileptogenicity.
- Open Access
Comprehensive Analysis of Human Dendritic Spine Morphology and Density: Exploring Diversity of Human Dendritic Spines
Dendritic spines, small protrusions on neuronal dendrites, play a crucial role in brain function by changing shape and size in response to neural activity. So far, in depth analysis of dendritic spines in human brain tissue is lacking. This study presents a comprehensive analysis of human dendritic spine morphology and density using a unique dataset from human brain tissue from 27 patients (8 females, 19 males, aged 18-71) undergoing tumor or epilepsy surgery at three neurosurgery sites. We used acute slices and organotypic brain slice cultures to examine dendritic spines, classifying them into the three main morphological subtypes: Mushroom, Thin, and Stubby, via 3D reconstruction using ZEISS arivis Pro software. A deep learning model, trained on 39 diverse datasets, automated spine segmentation and 3D reconstruction, achieving a 74% F1-score and reducing processing time by over 50%. We show significant differences in spine density by sex, dendrite type, and tissue condition. Females had higher spine densities than males, and apical dendrites were denser in spines than basal ones. Acute tissue showed higher spine densities compared to cultured human brain tissue. With time in culture, Mushroom spines decreased, while Stubby and Thin spine percentages increased, particularly from 7-9 to 14 days in vitro , reflecting potential synaptic plasticity changes. Our study underscores the importance of using human brain tissue to understand unique synaptic properties and shows that integrating deep learning with traditional methods enables efficient large-scale analysis, revealing key insights into sex- and tissue-specific dendritic spine dynamics relevant to neurological diseases. New and Noteworthy: This study presents a dataset of nearly 4,000 morphologically reconstructed human dendritic spines across different ages, gender, and tissue conditions. The dataset was further used to evaluate a deep learning algorithm for three-dimensional spine reconstruction, offering a scalable method for semi-automated spine analysis across various tissues and microscopy setups. The findings enhance understanding of human neurology, indicating potential connections between spine morphology, brain function, and the mechanisms of neurological and psychiatric diseases.
Open AccessComprehensive Analysis of Human Dendritic Spine Morphology and Density: Exploring Diversity of Human Dendritic Spines
Dendritic spines, small protrusions on neuronal dendrites, play a crucial role in brain function by changing shape and size in response to neural activity. So far, in depth analysis of dendritic spines in human brain tissue is lacking. This study presents a comprehensive analysis of human dendritic spine morphology and density using a unique dataset from human brain tissue from 27 patients (8 females, 19 males, aged 18-71) undergoing tumor or epilepsy surgery at three neurosurgery sites. We used acute slices and organotypic brain slice cultures to examine dendritic spines, classifying them into the three main morphological subtypes: Mushroom, Thin, and Stubby, via 3D reconstruction using ZEISS arivis Pro software. A deep learning model, trained on 39 diverse datasets, automated spine segmentation and 3D reconstruction, achieving a 74% F1-score and reducing processing time by over 50%. We show significant differences in spine density by sex, dendrite type, and tissue condition. Females had higher spine densities than males, and apical dendrites were denser in spines than basal ones. Acute tissue showed higher spine densities compared to cultured human brain tissue. With time in culture, Mushroom spines decreased, while Stubby and Thin spine percentages increased, particularly from 7-9 to 14 days in vitro , reflecting potential synaptic plasticity changes. Our study underscores the importance of using human brain tissue to understand unique synaptic properties and shows that integrating deep learning with traditional methods enables efficient large-scale analysis, revealing key insights into sex- and tissue-specific dendritic spine dynamics relevant to neurological diseases. New and Noteworthy: This study presents a dataset of nearly 4,000 morphologically reconstructed human dendritic spines across different ages, gender, and tissue conditions. The dataset was further used to evaluate a deep learning algorithm for three-dimensional spine reconstruction, offering a scalable method for semi-automated spine analysis across various tissues and microscopy setups. The findings enhance understanding of human neurology, indicating potential connections between spine morphology, brain function, and the mechanisms of neurological and psychiatric diseases.
- Open Access
Linking Altered Neuronal and Synaptic Properties to Nicotinic Receptor Alpha5 Subunit Gene Dysfunction: A Translational Investigation in Rat mPFC and Human Cortical Layer 6
Background: Genetic variation in the α5 nicotinic acetylcholine receptor (nAChR) subunit of mice results in behavioral deficits linked to the prefrontal cortex (PFC). A Single Nucleotide Polymorphisms (SNP) in CHRNA5 imparts a partial loss of function to the α5 subunit-containing (α5*) nAChRs and have been demonstrated to be associated with psychiatric disorders in humans, including schizophrenia, nicotine dependence, cocaine and alcohol addiction. Methods: We performed single cell-electrophysiology combined with morphological reconstructions on layer 6 (L6) excitatory neurons in the medial PFC (mPFC) of wild type (WT) rats (n = 25), rats carrying the human coding polymorphism rs16969968 in Chrna5 (n = 11) and α5 knockout (KO) rats (n = 28). Neuronal and synaptic properties were compared among three rat genotypes. Galantamine was applied to identified L6 neuron populations to specifically boost the nicotinic responses mediated by α5*nAChRs in the rat mPFC and human neocortex (n = 6 patients). Results: Compared with neurons in WT rats, L6 regular spiking (RS) neurons in the α5KO group exhibited altered electrophysiological properties, while those in α5SNP rats remained unchanged. L6 RS neurons in mPFC of α5SNP and α5KO rats differed from WT rats in dendritic morphology, spine density and spontaneous synaptic activity. Galantamine acted as a positive allosteric modulator of α5*nAChRs in RS but not burst spiking (BS) neurons in both rat and human cortical L6. Conclusion: Our findings suggest that dysfunction in the α5 subunit gene leads to aberrant neuronal and synaptic properties, shedding light on the underlying mechanisms of cognitive deficits observed in human populations carrying α5SNPs. They highlight a potential pharmacological target for restoring the relevant behavioral output.
Open AccessLinking Altered Neuronal and Synaptic Properties to Nicotinic Receptor Alpha5 Subunit Gene Dysfunction: A Translational Investigation in Rat mPFC and Human Cortical Layer 6
Background: Genetic variation in the α5 nicotinic acetylcholine receptor (nAChR) subunit of mice results in behavioral deficits linked to the prefrontal cortex (PFC). A Single Nucleotide Polymorphisms (SNP) in CHRNA5 imparts a partial loss of function to the α5 subunit-containing (α5*) nAChRs and have been demonstrated to be associated with psychiatric disorders in humans, including schizophrenia, nicotine dependence, cocaine and alcohol addiction. Methods: We performed single cell-electrophysiology combined with morphological reconstructions on layer 6 (L6) excitatory neurons in the medial PFC (mPFC) of wild type (WT) rats (n = 25), rats carrying the human coding polymorphism rs16969968 in Chrna5 (n = 11) and α5 knockout (KO) rats (n = 28). Neuronal and synaptic properties were compared among three rat genotypes. Galantamine was applied to identified L6 neuron populations to specifically boost the nicotinic responses mediated by α5*nAChRs in the rat mPFC and human neocortex (n = 6 patients). Results: Compared with neurons in WT rats, L6 regular spiking (RS) neurons in the α5KO group exhibited altered electrophysiological properties, while those in α5SNP rats remained unchanged. L6 RS neurons in mPFC of α5SNP and α5KO rats differed from WT rats in dendritic morphology, spine density and spontaneous synaptic activity. Galantamine acted as a positive allosteric modulator of α5*nAChRs in RS but not burst spiking (BS) neurons in both rat and human cortical L6. Conclusion: Our findings suggest that dysfunction in the α5 subunit gene leads to aberrant neuronal and synaptic properties, shedding light on the underlying mechanisms of cognitive deficits observed in human populations carrying α5SNPs. They highlight a potential pharmacological target for restoring the relevant behavioral output.
- Open Access
Long-term human organotypic brain slice cultures: a detailed protocol to provide a comprehensive framework for single-neuron and neuronal network investigations
Background: The investigation of the human brain at cellular and microcircuit level remains challenging due to the fragile viability of neuronal tissue, inter- and intra-variability of the samples and limited availability of human brain material. New method: Here, we present an optimized work-up to use resected tissue from brain surgeries for live cell experiments in vitro. Comparison with existing methods: We provide a reworked, detailed protocol of the production, culturing and viral transduction of human organotypic brain slice cultures for research purposes. Results: We highlight the critical pitfalls of the culturing process of the human brain tissue and present results on viral expression, single-cell Patch-Clamp recordings, as well as multi-electrode array recordings over a prolonged period of time. Additionally, our statistics show that brain tissue from patients of any age and morbidity can be used for organotypic brain slice cultures if carefully selected. Conclusions: Organotypic brain slice cultures are of great value for basic neuroscience and disease modeling over a time course of three weeks. Highlights: Long-term human organotypic brain slice cultures are viable for 2-3 weeks and provide a framework for basic neuroscience and disease modeling We provide a reworked, detailed protocol for organotypic human brain slice culture production and maintenance We show results of long-term culturing of human organotypic brain slice cultures in terms of viral transduction, whole-cell Patch-Clamp recordings and multi-electrode array recordings Statistics of 16 surgeries show the correlation between the overall success rates of efficient culturing and viral transduction with the patient age and morbidity Figure 1, Graphical Schematic overview of preparation, maintenance and experimental workup of human organotypic brain slice cultures.: After surgical resection, human brain tissue is prepared, sliced and cultured at air-liquid-interface between human cerebrospinal fluid and defined incubator atmosphere, allowing for week-long viability. This enables extensive experimental workup such as viral transduction, single cell and multi-electrode array electrophysiological recordings.
Open AccessLong-term human organotypic brain slice cultures: a detailed protocol to provide a comprehensive framework for single-neuron and neuronal network investigations
Background: The investigation of the human brain at cellular and microcircuit level remains challenging due to the fragile viability of neuronal tissue, inter- and intra-variability of the samples and limited availability of human brain material. New method: Here, we present an optimized work-up to use resected tissue from brain surgeries for live cell experiments in vitro. Comparison with existing methods: We provide a reworked, detailed protocol of the production, culturing and viral transduction of human organotypic brain slice cultures for research purposes. Results: We highlight the critical pitfalls of the culturing process of the human brain tissue and present results on viral expression, single-cell Patch-Clamp recordings, as well as multi-electrode array recordings over a prolonged period of time. Additionally, our statistics show that brain tissue from patients of any age and morbidity can be used for organotypic brain slice cultures if carefully selected. Conclusions: Organotypic brain slice cultures are of great value for basic neuroscience and disease modeling over a time course of three weeks. Highlights: Long-term human organotypic brain slice cultures are viable for 2-3 weeks and provide a framework for basic neuroscience and disease modeling We provide a reworked, detailed protocol for organotypic human brain slice culture production and maintenance We show results of long-term culturing of human organotypic brain slice cultures in terms of viral transduction, whole-cell Patch-Clamp recordings and multi-electrode array recordings Statistics of 16 surgeries show the correlation between the overall success rates of efficient culturing and viral transduction with the patient age and morbidity Figure 1, Graphical Schematic overview of preparation, maintenance and experimental workup of human organotypic brain slice cultures.: After surgical resection, human brain tissue is prepared, sliced and cultured at air-liquid-interface between human cerebrospinal fluid and defined incubator atmosphere, allowing for week-long viability. This enables extensive experimental workup such as viral transduction, single cell and multi-electrode array electrophysiological recordings.
- Open Access
- 20 April 2023
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 18 (12) , 2657-2658
‘Hippocampal innate inflammatory gliosis only’ – the future role of surgery in a novel temporal lobe epilepsy syndrome
- 20 April 2023
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 18 (12) , 2657-2658
Open Access‘Hippocampal innate inflammatory gliosis only’ – the future role of surgery in a novel temporal lobe epilepsy syndrome